Clear skies for UMediC

Lim: We expect cost stabilisation within the next six to 12 months.

ALTHOUGH UMediC Group Bhd was listed in 2022, it is still in the early stages of its growth. In the last five quarters, both the top line and bottom line of the medical device distributor and manufacturer declined year-over-year.

Lower demand for its products coupled with a spike in staff costs following an expansion of facilities are to blame.UMedic’s share price, which hit 86 sen about a year after it listed, has dipped to a low of 57 sen.